COMPANY

Rivanna Medical

HQ: Charlottesville, VA source · rivannamedical.com ↗ · Southeast

1 open job · last seen Oct 23, 2026 · 28 sources

Location: Charlottesville, VA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Rivanna Medical is a medical technology company developing clinical decision-support solutions powered by clinical datasets, AI models, and purpose-built imaging hardware. From company website Source · checked 2026-10-19

Sources for this description (1)

Rivanna Medical is a medical technology company developing clinical decision-support solutions powered by clinical datasets, AI models, and purpose-built imaging hardware.
- “RIVANNA ® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware.” https://rivannamedical.com/about-us/ (2026-10-19)

Keywords: analgesia chronic pain Fracture Leg Wrist Injury Ankle Injury

1Open jobs 1Trials (company is sponsor)5FDA records (2 yrs)19NIH grants

Hiring

Title	Location (from posting)	Employer posted	First seen
Join Our Innovative Team at Rivanna Medical, Inc.	Rivanna Medical, Inc.	Aug 27, 2024	Oct 16, 2026

See all 1 job

Funding and NIH signals

NIH award NIH awarded $1.1M (SBIR Phase II 5R44CA302033-02, continuation, notice Jul 14, 2026); 1 role open. NIH RePORTER 5R44CA302033-02 (Jul 14, 2026)
Evidence (1 event)
- Jul 14, 2026 · NIH RePORTER 5R44CA302033-02
  Organization: RIVANNA MEDICAL, INC.; City/State: CHARLOTTESVILLE, VA; Project number: 5R44CA302033-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-14; FY total cost (award amount): 1104515; Administering IC: National Cancer Institute; Project title: Reduced Traumatic Lumbar Puncture Rates in Pediatric Oncology Patients Through Development of an AI-Assisted, Ultrasound-Based Interventional Guidance Platform; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jul 24, 2026 FDA FDA 510(k) clearance: Accuro 3S — K253452, Jul 24, 2026. Applicant at approval: Rivanna Medical, Inc. source ↗
Jul 24, 2026 FDA FDA 510(k) clearance: Accuro® 3S Needle Guide Kit — K261014, Jul 24, 2026. Applicant at approval: Rivanna Medical, Inc. source ↗
Jul 14, 2026 Grant Government grant — SBIR: $1.1M (annual award, as published), announced Jul 14, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Apr 9, 2026 FDA FDA 510(k) clearance: Accuro XV — K254021, Apr 9, 2026. Applicant at approval: Rivanna Medical, Inc. source ↗
Jul 8, 2025 Grant Government grant — SBIR: $1.07M (annual award, as published), announced Jul 8, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Jun 13, 2025 FDA FDA 510(k) clearance: Accuro® 3S Needle Guide Kit — K250469, Jun 13, 2025. Applicant at approval: Rivanna Medical, Inc. source ↗
Jun 1, 2025 Grant Government grant: $3.05M (total, as published), announced Jun 1, 2025. Agency: DoD. Source: government award database. source ↗
May 23, 2025 FDA FDA 510(k) clearance: Accuro 3S — K243937, May 23, 2025. Applicant at approval: Rivanna Medical, Inc. source ↗
Jan 29, 2024 Trial start Not phased (device or behavioral study): Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms source ↗

Upcoming milestones

2027-08 (ESTIMATED) · Not phased · Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms · NCT07853768

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Last 2 years.

Jul 14, 2026 Government grant — SBIR: $1.1M (annual award, as published), announced Jul 14, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Jul 8, 2025 Government grant — SBIR: $1.07M (annual award, as published), announced Jul 8, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Jun 1, 2025 Government grant: $3.05M (total, as published), announced Jun 1, 2025. Agency: DoD. Source: government award database. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07853768	Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms	Not phased (device or behavioral study)	Recruiting	Jan 29, 2024	2027-08 (estimated)

FDA records (last 2 years)

Jul 24, 2026 FDA 510(k) clearance: Accuro 3S — K253452, Jul 24, 2026. Applicant at approval: Rivanna Medical, Inc. source ↗
Jul 24, 2026 FDA 510(k) clearance: Accuro® 3S Needle Guide Kit — K261014, Jul 24, 2026. Applicant at approval: Rivanna Medical, Inc. source ↗
Apr 9, 2026 FDA 510(k) clearance: Accuro XV — K254021, Apr 9, 2026. Applicant at approval: Rivanna Medical, Inc. source ↗
Jun 13, 2025 FDA 510(k) clearance: Accuro® 3S Needle Guide Kit — K250469, Jun 13, 2025. Applicant at approval: Rivanna Medical, Inc. source ↗
May 23, 2025 FDA 510(k) clearance: Accuro 3S — K243937, May 23, 2025. Applicant at approval: Rivanna Medical, Inc. source ↗

NIH awards 19

Annual award amounts. Total $13.5M.

Aug 30, 2024 NIH award 5R44AR083337-02 FY2024: $1,005,539 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Development of a regional a source ↗
Sep 11, 2023 NIH award 1R44AR083337-01 FY2023: $1,011,938 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Development of a regional a source ↗
Sep 1, 2023 NIH award 5R44NS120798-03 FY2023: $837,818 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Real-time three-dimensional s source ↗
Aug 9, 2023 NIH award 5SB1AR082178-02 FY2023: $342,003 awarded for that fiscal year; activity SB1 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Commercialization readiness f source ↗
Sep 21, 2022 NIH award 1SB1AR082178-01 FY2022: $403,074 awarded for that fiscal year; activity SB1 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Commercialization readiness f source ↗
Sep 2, 2022 NIH award 5R44AR080617-02 FY2022: $853,559 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Automated three-dimensional s source ↗
Aug 23, 2022 NIH award 5R44NS120798-02 FY2022: $830,602 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Real-time three-dimensional s source ↗
Sep 17, 2021 NIH award 1R44AR080617-01 FY2021: $877,193 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Automated three-dimensional s source ↗
Sep 7, 2021 NIH award 1R44NS120798-01A1 FY2021: $1,032,828 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Real-time three-dimension source ↗
May 4, 2021 NIH award 5R44CA246854-02 FY2021: $829,225 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Bedside ultrasound system for source ↗
Apr 30, 2020 NIH award 1R44CA246854-01A1 FY2020: $670,777 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Bedside ultrasound system f source ↗
Apr 16, 2018 NIH award 5R44GM123791-02 FY2018: $793,271 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Handheld ultrasound system fo source ↗
Aug 3, 2017 NIH award 5R44EB024384-03 FY2017: $746,394 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. 3D ultrasound for bone fractu source ↗
Apr 24, 2017 NIH award 1R44GM123791-01 FY2017: $704,777 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Handheld ultrasound system fo source ↗
Sep 21, 2016 NIH award 9R44EB024384-02A1 FY2016: $737,936 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. 3D ultrasound for bone frac source ↗
Jul 2, 2015 NIH award 5R44EB015232-03 FY2015: $555,760 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Low-cost handheld medical dev source ↗
Sep 17, 2014 NIH award 2R44EB015232-02 FY2014: $797,265 awarded for that fiscal year; activity R44 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Low-cost handheld medical dev source ↗
Jun 27, 2013 NIH award 1R43AR064106-01A1 FY2013: $210,419 awarded for that fiscal year; activity R43 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Portable 3D ultrasound for source ↗
Jul 8, 2012 NIH award 1R43EB015232-01A1 FY2012: $231,868 awarded for that fiscal year; activity R43 (SBIR); PI MAULDIN, FRANK WILLIAM; recipient as written: RIVANNA MEDICAL, INC., CHARLOTTESVILLE, VA. Low-cost handheld medical d source ↗

Open jobs 1

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Join Our Innovative Team at Rivanna Medical, Inc.	Rivanna Medical, Inc.	Aug 27, 2024	Oct 16, 2026	Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Rivanna Medical on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12